Cargando…
Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
BACKGROUND: Digoxin is a cardiac glycoside, derived from the plant Digitalis purpurea. For many years digitalis has been widely used in the treatment of heart failure (HF), owing to its cardiotonic and neurohormonal effects and atrial fibrillation (AF), due to its parasympathomimetic effect on the A...
Autores principales: | Gerakaris, Andreas, Mulita, Francesk, Koniari, Ioanna, Artopoulou, Eleni, Mplani, Virginia, Tsigkas, Grigorios, Abo-Elseoud, Mohammed, Kounis, Nicholas, Velissaris, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976896/ https://www.ncbi.nlm.nih.gov/pubmed/35422570 http://dx.doi.org/10.5455/medarh.2022.76.23-28 |
Ejemplares similares
-
Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021) -
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023) -
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
por: Koniari, Ioanna, et al.
Publicado: (2022)